- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Systemic Sclerosis
Total 190222 results
-
Heinrich-Heine University, DuesseldorfNovartis PharmaceuticalsTerminatedRelapsing Remitting Multiple SclerosisGermany
-
EMD SeronoTerminatedRelapsing Remitting Multiple SclerosisUnited States, Croatia, Bulgaria, Czech Republic, Italy, Mexico, Russian Federation, South Africa, Spain, Turkey, Hungary, Poland, Ukraine, Finland, United Kingdom, Greece, Serbia
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisItaly
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisRussian Federation
-
Merck KGaA, Darmstadt, GermanyMerck B.V., Netherlands; Merck A.E., Greece; Merck OY, Finland; Merck A.B., Sweden and other collaboratorsCompletedMultiple Sclerosis, Relapsing RemittingGreece
-
Fred LublinNational Institute of Neurological Disorders and Stroke (NINDS)CompletedRelapsing Remitting Multiple SclerosisUnited States, Canada
-
Genentech, Inc.CompletedMultiple SclerosisUnited States
-
Merck KGaA, Darmstadt, GermanyCompletedRelapsing Remitting Multiple Sclerosis
-
Ono Pharma USA IncCompletedMultiple SclerosisUnited States, Belgium, Canada, Czech Republic, Germany, Greece, Japan, Poland, Russian Federation, Spain, Ukraine
-
Teva Neuroscience, Inc.Completed
-
Nuron Biotech Inc.UnknownRelapsing Remitting Multiple SclerosisPoland, Spain, Belarus, Bulgaria, Serbia, Ukraine, Russian Federation, Hungary, Italy, Croatia, Georgia, Lebanon
-
BayerCompletedMultiple SclerosisUnited States, Canada
-
Tehran University of Medical SciencesUnknownRelapsing Remitting Multiple SclerosisIran, Islamic Republic of
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing Remitting Multiple Sclerosis
-
Wayne State UniversityCompleted
-
McGill UniversityInnodem NeurosciencesRecruitingClinically Isolated Syndrome | Relapsing Remitting Multiple SclerosisCanada
-
Hikma Pharmaceuticals LLCCompletedRelapsing Remitting Multiple SclerosisAlgeria, Egypt, Jordan
-
Regina Elena Cancer InstituteIcahn School of Medicine at Mount Sinai; University of Roma La SapienzaUnknownMultiple Sclerosis | RelapseUnited States, Italy
-
NovartisCompletedMultiple SclerosisUnited States, Korea, Republic of, Portugal, Canada, Hungary, Spain, Germany, United Kingdom, Australia, Argentina, Austria, Belgium, Brazil, Egypt, France, Greece, Italy, Switzerland
-
Prof. Ariane herrickVersus ArthritisCompleted
-
University of MalagaUnknownRelapsing-remitting Multiple SclerosisSpain
-
Shirley Ryan AbilityLabNorthwestern UniversityNot yet recruitingMultiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveUnited States
-
Stanford UniversityKyverna TherapeuticsRecruitingMultiple Sclerosis | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
Abu Dhabi Stem Cells CenterRecruitingMultiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveUnited Arab Emirates
-
Emmanuelle Waubant, MD PhDUnited States Department of DefenseRecruitingMultiple Sclerosis | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
Icahn School of Medicine at Mount SinaiWithdrawnRelapsing-remitting Multiple Sclerosis (RRMS)United States
-
BioMS Technology Corp.TerminatedMultiple Sclerosis, Secondary Progressive
-
University Hospital, Strasbourg, FranceCompletedSystemic Sclerosis | Early Systemic Sclerosis Without Clinical Scleroderma and Onset < 2 YearsFrance
-
AB ScienceRecruitingProgressive Multiple SclerosisSpain, Sweden, France, Greece, Italy, Poland, Russian Federation, Ukraine
-
Genzyme, a Sanofi CompanyCompletedProgressive Multiple SclerosisGermany
-
Somogy Megyei Kaposi Mór Teaching HospitalCompletedMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Primary ProgressiveHungary
-
NYU Langone HealthCompleted
-
IRCCS San RaffaeleFondazione Italiana Sclerosi MultiplaCompletedProgressive Multiple SclerosisItaly
-
Aristotle University Of ThessalonikiGreek Alzheimer's Association and Related Disorders; Ellis-Farm, Eliama Daily...CompletedProgressive Multiple SclerosisGreece
-
Rigshospitalet, DenmarkBiogenCompletedPrimary Progressive Multiple SclerosisDenmark
-
MedDay Pharmaceuticals SATerminatedMultiple SclerosisUnited States, Spain, Canada, Australia, United Kingdom, Belgium, Turkey, Czechia, Poland, Italy, Hungary, Germany, Sweden
-
South Valley UniversityCompleted
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisCzechia, Belgium
-
University Hospital, BordeauxCompletedMultiple Sclerosis | Multiple Sclerosis, Acute RelapsingFrance
-
Genentech, Inc.No longer availableMultiple SclerosisUnited States
-
Novartis PharmaceuticalsTerminatedPrimary Progressive Multiple SclerosisUnited States, Belgium, Poland, Germany, Hungary, Turkey, Spain, Australia, Canada, Czechia, Switzerland, United Kingdom, Netherlands, France, Italy, Denmark, Finland, Sweden
-
Institute for Clinical ResearchUnknownRelapsing-Remitting Multiple SclerosisUnited States
-
State University of New York at BuffaloCompletedSecondary-progressive Multiple SclerosisUnited States
-
Institut National de la Santé Et de la Recherche...BiogenUnknownNervous System Diseases | Progressive Multiple Sclerosis | Multiple Sclerosis | Eye Diseases | Optic Neuritis | Optic Nerve Diseases | Relapsing Remitting Multiple SclerosisFrance
-
Teva Branded Pharmaceutical Products R&D, Inc.Withdrawn
-
Réseau Sep Idf OuestCompletedFatigue | Relapsing Remitting Multiple Sclerosis | Cognitive TherapyFrance
-
Merck KGaA, Darmstadt, GermanyTerminatedMultiple Sclerosis, Relapsing-remittingGermany
-
BayerWithdrawnMultiple SclerosisSweden, Denmark
-
Cabaletta BioRecruitingSystemic Sclerosis | SclerodermaUnited States
-
University Hospital, BordeauxRecruitingSystemic Sclerosis | SclerodermaFrance